
    
      Secondary (exploratory) objectives

        -  To evaluate the impact of 300mL convP on mortality

        -  To evaluate the impact of 300mL convP on hospital admission

        -  To evaluate the impact of 300mL convP on admission to ICU

        -  To evaluate the impact of 300mL convP on duration of symptoms

        -  To evaluate the impact of 300mL convP in relation to the age and clinical frailty of the
           patient
    
  